和黄医药:2026年上半年净收益为1624万美元 同比降96.43%

财中社
Jul 30

7月30日,和黄医药(00013/HCM)发布2026年中期业绩,公司收入总额2.78亿美元,同比增长0.22%;净收益为1624万美元,同比减少96.43%;每股普通股基本盈利0.02美元。  在管理层讨论与分析中提到,爱优特®和苏泰达®的强劲市场销售反映了公司商业团队针对中国市场监管指引变化所采取的有效措施。此外,FRUZAQLA®在美国以外市场的销售额增长约70%至6890万美元,显示出公司...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10